Physician profile
Eural E Gordon
NPI 1174657514
$2,225.19
in general payments reported to CMS, 2019-2025
16 companies · $670 in 2025
The $670 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $262 · 2023: $734 · 2024: $559 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,962.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $353.94 | 2022-2025 | Mounjaro, Jardiance |
| Abbvie INC. | $347.87 | 2022-2024 | |
| Glaxosmithkline, LLC. | $183.98 | 2024 | Arexvy, Trelegy Ellipta |
| Medtronic, INC. | $174.72 | 2023-2025 | Venaseal, Contour 3d |
| Astrazeneca Pharmaceuticals Lp | $149.96 | 2024-2025 | Airsupra, Farxiga |
| Abiomed | $142.15 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $141.54 | 2022-2023 | Xifaxan |
| Otsuka America Pharmaceutical, INC. | $135.99 | 2023 | Rexulti |
| Novo Nordisk INC | $127.91 | 2024-2025 | Wegovy |
| Pfizer INC. | $113.67 | 2024-2025 | |
| Nevro Corp. | $100.48 | 2023-2024 | Senza |
| Abbott Laboratories | $94.80 | 2023 | Cardiomems |
| Antares Pharma, INC. | $82.64 | 2023 | Xyosted, Tlando |
| Dexcom, INC. | $42.12 | 2022-2025 | Dexcom G6 Transmitter |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.69 | 2025 | Caplyta |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $13.73 | 2025 | Zurzuvae |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eural Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.